Skip to Page Content

Ultra Thin Gadolinium Foil

Gd Nanometal™
CAS 7440-54-2


Product Product Code Request Quote
(3N) 99.9% Ultra Thin Gadolinium Foil GD-M-03-FN Request Quote
(4N) 99.99% Ultra Thin Gadolinium Foil GD-M-04-FN Request Quote
(5N) 99.999% Ultra Thin Gadolinium Foil GD-M-05-FN Request Quote

CHEMICAL
IDENTIFIER
Formula CAS No. PubChem SID PubChem CID MDL No. EC No Beilstein
Re. No.
SMILES
Identifier
InChI
Identifier
InChI
Key
Gd 7440-54-2 24855949 23982 MFCD00011022 231-162-2 N/A [Gd] InChI=1S/Gd UIWYJDYFSGRHKR-UHFFFAOYSA-N

PROPERTIES Mol. Wt. Appearance Density Tensile Strength Melting Point Boiling Point Thermal Conductivity Electrical Resistivity Eletronegativity Specific Heat Heat of Vaporization Heat of Fusion MSDS
157.25 Silvery 7901kg/m³ N/A 1312°C 3250°C 0.105 W/cm/K @ 298.2 K 140.5 microhm-cm @ 25°C 1.1 Paulings 0.055 Cal/g/K @ 25°C 72 K-Cal/gm atom at 3266°C 3.70 Cal/gm mole Safety Data Sheet

American Elements' Nanometal™ nanofoil manufacturing unit produces ultra thin foil as thin as only 50 nm thick in diameters up to 910 mm. Typically, foils are in thicknesses from 20 nm to 1000 nm, 1 micron, 2 micron, and up to a few microns thick. Nanometal™ ultra thin foil can also be produced on a substrate with a parting agent to permit removal by floating and can then be mounted on frames. Frames may be washers, rings, or more-complicated assemblies. For foils >1 micron thick see our Gadolinium Foil page. We also produce Gadolinium as rods, powder and plates. Other shapes are available by request.

Gadolinium Element SymbolGadolinium (atomic symbol: Gd, atomic number: 64) is a Block F, Group 3, Period 6 element with an atomic radius of 157.25.Gadolinium Bohr Model The number of electrons in each of Gadolinium's shells is [2, 8, 18, 25, 9, 2] and its electron configuration is [Xe] 4f7 5d1 6s2. The gadolinium atom has a radius of 180 pm and a Van der Waals radius of 237 pm. Gadolinium was discovered by Jean Charles Galissard de Marignac in 1880 and first isolated by Lecoq de Boisbaudran in 1886. In its elemental form, gadolinium has a silvery-white appearance. Gadolinium is a rare earth or lanthanide element that possesses unique properties advantageous Elemental Gadolinium Pictureto specialized applications such as semiconductor fabrication and nuclear reactor shielding. It is utilized for both its high magnetic moment (7.94μB) and in phosphors and scintillator crystals. When complexed with EDTA ligands, it is used as an injectable contrast agent for MRIs. The element is named after the Finnish chemist and geologist Johan Gadolin. For more information on Gadolinium, including properties, satefy data, research, and American Elements' catalog of Gadolinium products, visit the Gadolinium element page.


HEALTH, SAFETY & TRANSPORTATION INFORMATION
Warning
H261
N/A
N/A
N/A
N/A
UN 3208 4.3/PG 3
3
Flame-Flammables        

CUSTOMERS FOR ULTRA THIN GADOLINIUM FOIL HAVE ALSO LOOKED AT
Gadolinium Oxide Gadolinium Oxide Nanopowder Gadolinium Sputtering Target Gadolinium Oxide Pellets Gadolinium Acetylacetonate
Gadolinium Pellets Gadolinium Powder Gadolinium Acetate Gadolinium Pellets Gadolium Phosphide
Gadolinium Metal Gadolinia Doped Ceria Gadolinium Foil Gadolinium Chloride Gadolinium Nitrate
Show Me MORE Forms of Gadolinium

PACKAGING SPECIFICATIONS FOR BULK & RESEARCH QUANTITIES
Typical bulk packaging includes palletized plastic 5 gallon/25 kg. pails, fiber and steel drums to 1 ton super sacks in full container (FCL) or truck load (T/L) quantities. Research and sample quantities and hygroscopic, oxidizing or other air sensitive materials may be packaged under argon or vacuum. Shipping documentation includes a Certificate of Analysis and Material Safety Data Sheet (MSDS). Solutions are packaged in polypropylene, plastic or glass jars up to palletized 440 gallon liquid totes.


Have a Question? Ask a Chemical Engineer or Material Scientist
Request an MSDS or Certificate of Analysis

Recent Research & Development for Gadolinium

  • Gadolinium Enhanced MR-angiography Results in Patients With Peripheral Arterial Disease: Positive Predictive Value Compared to Surgery. Mirsharifi SR, Noparast M, Khazravi M, Ghanaati H, Shakiba M, Sharifi A. Iran Red Crescent Med J. 2014 Dec 25
  • Determination of selenium in serum in the presence of gadolinium with ICP-QQQ-MS. Bishop DP, Hare DJ, Fryer F, Taudte RV, Cardoso BR, Cole N, Doble PA. Analyst. 2015 Mar 2.
  • Importance of Outer-Sphere and Aggregation Phenomena in the Relaxation Properties of Phosphonated Gadolinium Complexes with Potential Applications as MRI Contrast Agents. Elhabiri M, Abada S, Sy M, Nonat A, Choquet P, Esteban-Gómez D, Cassino C, Platas-Iglesias C, Botta M, Charbonnière LJ. Chemistry. 2015 Mar 6.
  • Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Radiology. 2015 Mar 5:150025.
  • Gadolinium Chelate Contrast Material in Pregnancy: Fetal Biodistribution in the Nonhuman Primate. Oh KY, Roberts VH, Schabel MC, Grove KL, Woods M, Frias AE. Radiology. 2015 Mar 11:141488.
  • Modified wideband three-dimensional late gadolinium enhancement MRI for patients with implantable cardiac devices. Rashid S, Rapacchi S, Shivkumar K, Plotnik A, Finn JP, Hu P. Magn Reson Med. 2015 Mar 13.
  • Pathologic correlates of late gadolinium enhancement cardiovascular magnetic resonance in a heart transplant patient. Pedrotti P, Bonacina E, Vittori C, Frigerio M, Roghi A. Cardiovasc Pathol. 2015 Feb 10.
  • Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Lux F, Sancey L, Bianchi A, Crémillieux Y, Roux S, Tillement O. Nanomedicine (Lond). 2015 Feb 25:1-15.
  • Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy. Tateishi E, Noguchi T, Goto Y, Morita Y, Ishibashi-Ueda H, Yamada N, Kanzaki H, Nishimura K, Miyamoto Y, Anzai T, Ogawa H, Yasuda S. Heart. 2015 Mar 11.
  • Late Gadolinium Enhancement Imaging in Assessment of Myocardial Viability: Techniques and Clinical Applications. Jimenez Juan L, Crean AM, Wintersperger BJ. Radiol Clin North Am. 2015 Mar
  • Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière's disease. Liu Y, Jia H, Shi J, Zheng H, Li Y, Yang J, Wu H. Med Sci Monit. 2015 Mar 6
  • Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: Role of pharmaceutical formulation. Fretellier N, Salhi M, Schroeder J, Siegmund H, Chevalier T, Bruneval P, Jestin-Mayer G, Delaloge F, Factor C, Mayer JF, Fabicki JM, Robic C, Bonnemain B, Idée JM, Corot C. Eur J Pharm Sci. 2015 Feb 28.
  • Gadolinium modifies the cell membrane to inhibit permeabilization by nanosecond electric pulses. Gianulis EC, Pakhomov AG. Arch Biochem Biophys. 2015 Feb 21
  • Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy. Naeger DM, Higgins C, De Marco T, Muzzarelli S, Ordovas KG. Clin Imaging. 2015 Jan 14.
  • Improved Wall Motion of Late Gadolinium-Enhanced Myocardium After Complete Surgical Revascularization. Oh SJ, Park EA, Lee W, Hwang HY, Kim KB. Ann Thorac Surg. 2015 Mar 7.
  • One-step synthesis of gradient gadolinium ironhexacyanoferrate nanoparticles: a new particle design easily combining MRI contrast and photothermal therapy. Li Y, Li CH, Talham DR. Nanoscale. 2015 Mar 12
  • Late gadolinium enhancement in sarcoidosis: ventricular wall stress should not be overlooked. Alter P, Vogelmeier CF, Koczulla AR. Chest. 2015 Mar 1